Christopher Dinsmore is CSO at Kronos Bio, Inc. (KRON). They have made 10 open-market trades across 1 company since 2020, most recently 2024-01-04.
CIK 0001826766
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2020, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KRON | 260,969 | $230K |
Shares reported on the most recent Form 4, priced at the 2024-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRON | SELL | 2024-01-04 | 2024-01-05 | $1.18 | $9K | -8.7% | -8.7% | +4.3% |
| KRON | SELL | 2023-12-12 | 2023-12-13 | $1.31 | $13K | -12.4% | -18.6% | -22.4% |
| KRON | SELL | 2023-07-06 | 2023-07-07 | $1.75 | $12K | +11.1% | -16.1% | -35.2% |
| KRON | SELL | 2023-02-24 | 2023-02-24 | $1.74 | $11K | -2.9% | -17.0% | -6.4% |
| KRON | SELL | 2022-12-12 | 2022-12-14 | $1.81 | $17K | -20.2% | +35.8% | -17.6% |
| KRON | SELL | 2021-12-13 | 2021-12-15 | $12.36 | $279K | +10.0% | -21.1% | -47.3% |
| KRON | SELL | 2021-10-04 | 2021-10-04 | $20.81 | $382K | -21.5% | -12.9% | -31.0% |
| KRON | SELL | 2021-09-07 | 2021-09-09 | $21.91 | $403K | +4.5% | -24.0% | -40.8% |
| KRON | SELL | 2021-08-02 | 2021-08-03 | $20.59 | $378K | +0.1% | +6.2% | -10.2% |
| KRON | BUY | 2020-10-14 | 2020-10-16 | $19.00 | $100K | -7.0% | -5.8% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.